Helping to advance revolutionary research in prostate cancer and delivery of precision treatments to U.S. Veterans, the John and Daria Barry Foundation has generously donated $2.5 million to the Prostate Cancer Foundation (PCF) to establish the John and Daria Barry Precision Oncology Center of Excellence at the Manhattan VA. Celebrating the momentous occasion, the upcoming VALOR Ceremony will honor U.S. Veterans battling prostate cancer during National Veterans and Military Families Month. John and Daria Barry will be accepting a special award on behalf of the Barry Foundation for their groundbreaking philanthropy.
The John and Daria Barry Precision Oncology Center of Excellence will serve as a precision oncology hub in the PCF’s preeminent network of centers working to fulfill the ambitious mission of improving the care of U.S. Veterans with prostate cancer in the New York metropolitan area and beyond. The PCF has committed to funding a series of precision medicine teams at leading VA medical centers and universities across the country. The John and Daria Barry Foundation’s gift will serve the nation’s heroes by delivering first-in-class prostate cancer care to U.S. Veterans and will pave the way for transformational research that will have a far lasting impact on generations to come.
One out of every nine men will be diagnosed with prostate cancer. It is the most frequently diagnosed cancer among Veterans, accounting for a third of all male cancer cases. African-American men, who represent the largest population group within the VA are 73% more likely to develop prostate cancer and are 2.3 times more likely to die from the disease than any other ethnicity. To date, little is known about the biological reasons for the alarming disparities. For more information, visit www.PCF.org.